GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Middle East Pharmaceutical Industries Co (SAU:4016) » Definitions » YoY EBITDA Growth

Middle East Pharmaceutical Industries Co (SAU:4016) YoY EBITDA Growth : 77.03% (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Middle East Pharmaceutical Industries Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Middle East Pharmaceutical Industries Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 77.03%.

Middle East Pharmaceutical Industries Co's EBITDA per Share for the three months ended in Mar. 2025 was ﷼1.29.

Middle East Pharmaceutical Industries Co YoY EBITDA Growth Historical Data

The historical data trend for Middle East Pharmaceutical Industries Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Middle East Pharmaceutical Industries Co YoY EBITDA Growth Chart

Middle East Pharmaceutical Industries Co Annual Data
Trend Dec23 Dec24
YoY EBITDA Growth
- 22.25

Middle East Pharmaceutical Industries Co Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial - 18.00 27.96 2.61 77.03

Middle East Pharmaceutical Industries Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Middle East Pharmaceutical Industries Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(5.16-4.221)/ | 4.221 |
=22.25 %

Middle East Pharmaceutical Industries Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(1.287-0.727)/ | 0.727 |
=77.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Middle East Pharmaceutical Industries Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Middle East Pharmaceutical Industries Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Middle East Pharmaceutical Industries Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Middle East Pharmaceutical Industries Co (SAU:4016) » Definitions » YoY EBITDA Growth
Comparable Companies
SAU:2070 SAU:2230 SAU:4015 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA SHSE:688506 TSE:4507 BOM:500087 SZSE:000538 NSE:TORNTPHARM UTHR BOM:500124
Traded in Other Exchanges
N/A
Address
8146 King Muhammad V, Sulaimaniyah, P.O. Box 4180, Riyadh, SAU, 11491
Website
Middle East Pharmaceutical Industries Co is a holding company is engaged in manufacturing medicines, medicated and non-medicated creams and gels. The company operates in Private, Public, and Export segments.

Middle East Pharmaceutical Industries Co Headlines

No Headlines